![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Frampton James E. Lyseng-Williamson Katherine A.
Publisher: Adis International
ISSN: 0012-6667
Source: Drugs, Vol.69, Iss.3, 2009-02, pp. : 307-317
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Wang Yow-Ming Sloey Bethlyn Wong Teresa Khandelwal Prerna Melara Rebeca Sun Yu-Nien
Pharmaceutical Research, Vol. 28, Iss. 8, 2011-08 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Romiplostim: Cerebral venous thrombosis: case report
Reactions Weekly, Vol. 1, Iss. 1409, 2012-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Cytarabine/methotrexate: Thrombocytopenia treated with romiplostim: case report
Reactions Weekly, Vol. 1, Iss. 1351, 2011-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Romiplostim: Leukaemia cutis in an elderly patient: case report
Reactions Weekly, Vol. 1, Iss. 1419, 2012-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Romiplostim: First report of haemorrhagic disorders: case report
Reactions Weekly, Vol. 1, Iss. 1391, 2012-01 ,pp. :